HIV-related pulmonary disorders: Practice issues

Annals of Tropical Paediatrics

Volumn 27, Issue 4, 2007, Pages 243-252

  Graham, S Mulanje ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; GANCICLOVIR; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; OXYGEN; PENICILLIN G; PREDNISONE; PROTEINASE INHIBITOR; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIMETHOPRIM; TUBERCULOSTATIC AGENT; VINCRISTINE;

HUMAN IMMUNODEFICIENCY VIRUS; MORBIDITY; MORTALITY; PNEUMONIA; TUBERCULOSIS;

BACTERIAL PNEUMONIA; BRONCHIECTASIS; CAUSE OF DEATH; CHILDHOOD MORTALITY; CHRONIC LUNG DISEASE; COMBINATION CHEMOTHERAPY; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; INTERSTITIAL PNEUMONIA; KAPOSI SARCOMA; LUNG DISEASE; LUNG MYCOSIS; LUNG TUBERCULOSIS; MONOTHERAPY; MORBIDITY; ONSET AGE; PNEUMOCYSTIS PNEUMONIA; RESOURCE MANAGEMENT; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

ACUTE DISEASE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; LUNG DISEASES; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NEGIBACTERIA; PNEUMOCYSTIS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 36448943954     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532807X245625     Document Type: Review

References (49)

1. Graham SM. Impact of HIV on childhood respiratory illness: diJerences between developing and developed countries. Pediatr Pulmonol 2003; 36:462-8.
2. United Nations Children's Fund/World Health Organization. Pneumonia: The Forgotten Killer of Children. New York, NY: UNICEF/WHO, 2006.
3. United Nations Children's Fund. The State of the World's Children. New York, NY: UNICEF, 2006.
4. Graham SM, Coulter JB, Gilks CF. Pulmonary disease in HIV-infected African children, Int J Tuberc Lung Dis 2001; 5:12-23.
5. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin lnfect Dis 2000; 31:170-6.
6. Graham SM, Mtitimila EI, Kamanga HS, Walsh AL, Hart CA, Molyneux ME. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet 2000; 355:369-73.
7. Zar HJ, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 2001; 90:119-25.
8. Bakeera-Kitaka S, Musoke P, Downing R, Tumwine JK. Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda. Ann Trop Paediatr 2004; 24:227-35.
9. McNally LM, Jeena PM, Gajee K, et al. EJect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007; 369:1440-51.
10. Graham SM. Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children. Int J Tuberc Lung Dis 2005; 9:592-602.
11. Kiwanuka J, Graham SM, Coulter JB, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr 2001; 21:5-14.
12. World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-limited Settings, Towards Universal Access: Recommendations for a Public Health Approach. Geneva: WHO, 2006.
13. Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges of childhood TB in the era of HIV. J Infect Dis 2007; 196:S76-S85.
14. Grant AD, Sidibe K, Domoua K, et al. Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 1998; 2:926-34.
15. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002; 6:55-63.
16. Perez MS, van Dyke RB. Pulmonary infections in children with HIV infection. Semin Respir Infect 2002; 17:33-46.
17. Lucas SB, Peacock CS, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. Br Med J 1996; 312:335-8.
18. Coovadia HM, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuberc Lung Dis 1998; 2:844-51.
19. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360:985-90.
20. van Oosterhout JJ, Lanfer MK, Graham SM, et al. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr 2005; 39:626-31.
21. Laufer MK, Van Oosterhout JJG, Perez MA, et al. Observational cohort study of HIV-infected African children. Pediatr Infect Dis J 2006; 25:623-627
22. Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 2002; 6:672-8.
23. Palme IB, Gudetta B, Bruckfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21:1053-61.
24. World Health Organization. Acute Respiratory Infections in Children Case Management in Small Hospitals in Developing Countries. A manual for Doctors and Other Senior Health Workers. Geneva: WHO, 1990.
25. Shann F. The management of pneumonia in children in developing countries. Clin Infect Dis 1995; 21 (Suppl 3):S218-25.
26. World Health Organization. Management of the Child with a Serious Infection or Severe Malnutrition. Guidelines for Care at Rirst-referral Level in Developing Countries. Geneva: WHO, 2000.
27. World Health Organization. Management of Children with Pneumonia and H1V in Low-resource Settings: Report of a Consultative Meeting, Harare, Zimbabwe, 30-31 January, 2003. Geneva: WHO, 2004.
28. World Health Organization. Technical Updates of the Guidelines on the Integrated Management of Childhood Illness (IMCI): Evidence and Recommendations for Further Adaptations. Geneva: WHO, 2005.
29. Ayieko P, English M. Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 2007; 26:432-40.
30. Madhi SA, Petersen K, Khoosal M, et al. Reduced eJectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 2002; 21:315-21.
31. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J 2003; 22:43-7.
32. Williams AJ, Duong T, McNally LM, et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS 2001; 15:335-9.
33. World Health Organization. Guidelines on Cotrimoxazole Prophylaxis for HIV-Related Infections among Children, Adolescents and Adults in Resource-limited Settings: Recommendations for a Public Health Approach. Geneva: WHO, 2006.
34. Shata AM, Coulter JB, Parry CM, Ching'ani G, Broadhead RL, Hart CA. Sputum induction for the diagnosis of tuberculosis. Arch Dis Child 1996; 74:535-7.
35. Zar HJ, Tannenbaum E, Apolles P, Roux P, Hanslo D, Hussey G. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child 2000; 82:305-8.
36. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58.
37. Hesseling AC, Schaaf HS, Hanekom WA, et al. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 2003; 37:1226-33.
38. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull WHO 2003; 81:61-70.
39. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990; 323:160-4.
40. Madhi SA, Schoub B, Simmank K, Blackburn N, Klugman KP. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 2000; 137:78-84.
41. Madhi SA, Ramasamy N, Petersen K, Madhi A, Klugman KP. Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Eur J Clin Microbiol Infect Dis 2002; 21:499-505.
42. Madhi SA, Ramasamy N, Bessellar TG, Saloojee H, Klugman KP. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J 2002; 21:291-7.
43. Sheikh S, Madiraju K, Steiner P, Rao M. Bronchiectasis in pediatric AIDS. Chest 1997; 112:1202-7.
44. Mofenson LM, Oleske J, Serchuck L, Van Dyke R, Wilfert C. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53 (RR-14):1-92.
45. Chintu C, Bhat GJ, Walker AS, et al. Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004; 364:1865-71.
46. Mulenga V, Ford D, Walker AS, et al. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS 2007; 21:77-84.
47. Graham SM. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet 2002; 360:1966-8.
48. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 2004; 18:1905-13.
49. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. Br Med J 2003; 327:1019.